Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6MUY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,084
Award facts
- Contract value 100% obligated
- $16,083.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 29, 2025, valued at $16,083.61 for the supply of Otezla 30 mg tablets (60-count packages). The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025, and was awarded on a non-competitive, unrestricted basis. The funding agency is the Defense Logistics Agency's Medical Supply Chain, a defense-focused entity responsible for procuring and distributing pharmaceutical and medical products to support military healthcare operations. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent contract enables AmerisourceBergen to serve multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, by supplying a diverse portfolio of pharmaceutical products and medical supplies across numerous therapeutic domains. Otezla, an immunosuppressant medication used in dermatological and rheumatological treatments, represents one of the specialized brand-name pharmaceuticals the company routinely delivers through its federal contracts.
Quick answers
Who was awarded contract SPE2DX25F6MUY?
SPE2DX25F6MUY was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on April 29, 2025.
How much is contract SPE2DX25F6MUY worth?
The government has obligated $16,084 on SPE2DX25F6MUY.
Is contract SPE2DX25F6MUY an order under another contract?
Yes. SPE2DX25F6MUY is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6MUY competed?
The extent of competition for SPE2DX25F6MUY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award